Since CC-220 and CC-92480 show considerable potential for drastic protein degradation of IKZF1 and IKZF3 at low doses52,53, 6-position modification on CC-220 or CC-92480 may be a more selective and effective thalidomide derivative for the treatment of MM. Here, IKZF3 is linked to Miyoshi myopathy.